title: Postprandial serum cholylglycine as a marker of antituberculous drug hepatotoxicity in HIV-infected patients.
authors.forename: J
authors.initials: J
authors.lastname: Alegre
authors.forename: T
authors.initials: T
authors.lastname: Fernandez de Sevilla
authors.forename: V
authors.initials: V
authors.lastname: Falcó
authors.forename: L
authors.initials: L
authors.lastname: Armadans
authors.forename: J M
authors.initials: JM
authors.lastname: Martínez Vázquez
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D004435:Eating; D006000:Glycocholic Acid / Q000097:blood*; D006801:Humans; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D006000:Glycocholic Acid